IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that RD SET™ sensors with Masimo Measure-through Motion and Low Perfusion™ SET ® pulse oximetry have received FDA clearance with ...
Irvine, CA-based Masimo Corporation MASI recently announced the 510(k) clearance and full-market release of its proprietary Rad-97 Pulse CO-Oximeter. The launch of Rad-97 offers Masimo noninvasive and ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Masimo (NASDAQ: MASI) announced today the CE marking of Eve™, a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97™ Pulse CO-Oximeter ®. Eve combines the power of ...
Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...
Masimo (NASDAQ: MASI) announced today the CE marking of the Rad-97 ™ Pulse CO-Oximeter ®. Rad-97 offers the same Measure-through Motion and Low Perfusion™ SET ® pulse oximetry and upgradeable rainbow ...
DUBAI, United Arab Emirates — Masimo (NASDAQ: MASI) announced today that the United Arab Emirates (UAE) Ministry of Health & Prevention (MOHAP) is adopting a national screening protocol for critical ...
Improved SpO 2 Accuracy Now Available for All Patient Populations IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that RD SET ® sensors with Masimo Measure-through Motion and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results